HomeCompareASNB vs EPRT

ASNB vs EPRT: Dividend Comparison 2026

ASNB yields 1058.82% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASNB wins by $31071345.44M in total portfolio value
10 years
ASNB
ASNB
● Live price
1058.82%
Share price
$0.85
Annual div
$9.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31071345.51M
Annual income
$26,203,152,977,635.43
Full ASNB calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — ASNB vs EPRT

📍 ASNB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASNBEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASNB + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASNB pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASNB
Annual income on $10K today (after 15% tax)
$90,000.00/yr
After 10yr DRIP, annual income (after tax)
$22,272,680,030,990.11/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, ASNB beats the other by $22,272,680,019,794.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASNB + EPRT for your $10,000?

ASNB: 50%EPRT: 50%
100% EPRT50/50100% ASNB
Portfolio after 10yr
$15535672.79M
Annual income
$13,101,576,495,403.14/yr
Blended yield
84.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

ASNB
No analyst data
Altman Z
-0.8
Piotroski
1/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASNB buys
0
EPRT buys
0
No recent congressional trades found for ASNB or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASNBEPRT
Forward yield1058.82%3.97%
Annual dividend / share$9.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$31071345.51M$64.3K
Annual income after 10y$26,203,152,977,635.43$13,170.85
Total dividends collected$30702285.77M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ASNB vs EPRT ($10,000, DRIP)

YearASNB PortfolioASNB Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$116,582$105,882.35$11,212$512.01+$105.4KASNB
2$1,278,389$1,153,646.15$12,689$692.09+$1.27MASNB
3$13,190,644$11,822,767.40$14,521$944.30+$13.18MASNB
4$128,122,756$114,008,766.65$16,841$1,302.88+$128.11MASNB
5$1,172,030,327$1,034,938,978.31$19,841$1,821.64+$1172.01MASNB
6$10,102,040,479$8,847,968,029.27$23,818$2,587.47+$10102.02MASNB
7$82,083,001,031$71,273,817,718.63$29,230$3,744.65+$82082.97MASNB
8$629,069,410,336$541,240,599,232.35$36,816$5,540.38+$629069.37MASNB
9$4,549,712,643,140$3,876,608,374,080.81$47,806$8,413.17+$4549712.60MASNB
10$31,071,345,505,795$26,203,152,977,635.43$64,324$13,170.85+$31071345.44MASNB

ASNB vs EPRT: Complete Analysis 2026

ASNBStock

EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.

Full ASNB Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this ASNB vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASNB vs SCHDASNB vs JEPIASNB vs OASNB vs KOASNB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.